Global HEOR Strategy Lead, Payer & Value Insights

UCB S.A.

Slough

Hybrid

GBP 90,000 - 130,000

Full time

6 days ago
Be an early applicant
Application generator

An application made for this job — a tailored resume and cover letter that speak straight to the posting.

Get past ATS filters

Benefits offered by this job

Hybrid work model
Global exposure

Job summary

UCB S.A. is seeking a strategic HEOR Strategy Lead to shape global payer evidence and HTA strategies across the product lifecycle. You will join the Patient Evidence team and influence development and commercialization with evidence generation plans.

Based in Brussels, Slough, or Monheim, this hybrid role offers collaboration across markets and functions, including real world evidence, medical affairs, and clinical development.

Qualifications

  • Master's degree or PhD in Health Economics, Market Access, Outcomes Research, Public Health, Epidemiology, Pharmacy, or related field.
  • 8+ years of pharma industry experience, including consultancy where relevant.
  • Experience in global or matrix organizations with intercontinental exposure.

Responsibilities

  • Develop and refine global HEOR and payer evidence strategies aligned with asset and market access objectives.
  • Design and deliver HEOR evidence generation activities including cost-effectiveness and budget impact models, literature reviews, and QoL studies.
  • Build asset value assessments and support pricing and value strategies.
  • Communicate economic value stories for assets and indications.
  • Influence clinical development programs to meet payer HTA requirements globally.
  • Represent HTA and payer perspectives within cross-functional teams.

Skills

Health economics
Outcome research
Strategic thinking
Stakeholder management
Leadership
Communication skills

Education

Master's degree or PhD in Health Economics or related field

Tools

HEOR modelling tools

Job description

UCB S.A. is seeking a strategic HEOR Strategy Lead to shape global payer evidence and HTA strategies across the product lifecycle. You will join the Patient Evidence team and influence development and commercialization with evidence generation plans.

Based in Brussels, Slough, or Monheim, this hybrid role offers collaboration across markets and functions, including real world evidence, medical affairs, and clinical development.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Global HEOR Strategy Lead: Payer Evidence & Access
Global HEOR Strategy Lead: Payer Evidence & Access

UCB • Slough

Hybrid
GBP 90,000 - 130,000
Health Economic & Outcomes Research Strategy Lead (UK)
Health Economic & Outcomes Research Strategy Lead (UK)

UCB • Slough

Hybrid
GBP 90,000 - 130,000
Health Economic & Outcomes Research Strategy Lead (UK)
Health Economic & Outcomes Research Strategy Lead (UK)

UCB S.A. • Slough

Hybrid
GBP 90,000 - 130,000
Hybrid work model
Global exposure
Health Economics Lead - Payer Value Strategy
Health Economics Lead - Payer Value Strategy

UCB • Slough

Hybrid
GBP 65,000 - 90,000
Senior HEOR Expert – Rare Disease, Global Access
Senior HEOR Expert – Rare Disease, Global Access

UCB • Slough

Hybrid
GBP 90,000 - 130,000
Global HEOR Lead: Evidence & Market Access Strategy
Global HEOR Lead: Evidence & Market Access Strategy

Grünenthal Group • Maidenhead

On-site
GBP 80,000 - 120,000
Senior HEOR Strategy Lead – UK, Ireland & Nordics
Senior HEOR Strategy Lead – UK, Ireland & Nordics

Bristol-Myers Squibb Co • Denham

On-site
GBP 150,000 - 200,000
Comprehensive benefits
Flexible working
Inclusion & wellbeing programs
Global HEOR & HTA Director, Immunology
Global HEOR & HTA Director, Immunology

Novartis • City Of London

Hybrid
GBP 87,000 - 162,000
Insurance plans
Retirement plans
Wellbeing resources
+2
Health Economics & Outcomes Research Senior Expert - Rare Disease (UK)
Health Economics & Outcomes Research Senior Expert - Rare Disease (UK)

UCB • Slough

Hybrid
GBP 90,000 - 130,000
Head of HEOR UK & Nordics — Value & Access Strategy
Head of HEOR UK & Nordics — Value & Access Strategy

Bristol Myers Squibb EU Policy • Uxbridge

Hybrid
GBP 120,000 - 160,000
Flexible working
Comprehensive benefits